does nice say cbt works better than antidepressants for milder depression?
“Uh and indeed, NICE, which is the British organization that passes on what treatments the National Health Service will support and which ones are uh sufficiently evidence-based, um has come to that same conclusion.”
a guest, historian of psychiatry (Andrew Scull) said on Lex Fridman Podcast, 2026-09-20, at 18:12. hear it in context → the speaker cited: NICE.
first, the part that holds
the policy part is right: england's 2022 depression guideline (ng222) says not to routinely offer antidepressants as first-line treatment for less severe depression unless the person prefers them, and it lists cbt among the options it puts ahead of medication.
what we found when we went and looked
we read peer-reviewed papers that quote or summarize ng222. nice's own site and the ncbi bookshelf copy blocked automated access, so we could not read the guideline text in its original home. those papers say ng222 does not recommend antidepressants as routine first-line treatment for less severe depression (phq-9 under 16), offers them only when that is the person's informed preference, and puts individual cbt in the top four of 11 ranked first-line options. that ranking is not a finding that cbt "works better", though. it is an order of recommended use that mixes clinical effectiveness, cost-effectiveness and implementation, and group treatments come first largely because they are cheaper. the largest head-to-head network meta-analysis we read (101 trials, 11,910 patients, mostly moderate to severe depression) found no significant short-term difference between psychotherapy and medication (rr 0.99), with some signs that psychotherapy did better at 6-12 months.
assertion by assertion
| assertion | verdict | what the record says |
|---|---|---|
| nice guidance says antidepressants should not be the routine first-line treatment for less severe (milder) depression | confirmed | a 2026 british journal of general practice paper says ng222 "does not recommend antidepressants as a routine or first-line treatment for less severe depression" and that they "may be offered only if this is the person's preference". this is a secondary source quoting the guideline. we could not fetch nice's own page. [1][4] |
| nice ranks cbt ahead of antidepressants for less severe depression | confirmed | ng222 ranks 11 first-line treatments for less severe depression. group therapies come highest, mostly for cost reasons, and individual cbt and behavioural activation are in the top four. first-line options named include guided self-help, group cbt and group behavioural activation. antidepressants are not routine first-line. [1][2] |
| nice concludes that cbt works better than antidepressants for milder depression | overstated | the order is an order of recommended use that combines clinical effectiveness, cost-effectiveness and implementation. the cheapest, least intrusive options are listed first, and any option can still be used first line if the person prefers it. so the ranking is not a head-to-head verdict that cbt beats medication. a committee line that 'some psychological therapies were more effective than antidepressants' circulates in trade press, but we could not read it in a primary or allowed source. [1][2] |
| popular framing: trials show cbt beats antidepressants | overstated | a network meta-analysis of 101 trials (11,910 patients) found no significant difference between psychotherapy alone and medication alone at the end of treatment (rr 0.99, 95% ci 0.92-1.08). there were indications that psychotherapy did better at 6-12 months, and combined treatment did best for moderate depression. most of the trials were in moderate to severe depression, not milder depression. [3] |
| 'milder' depression in ng222 means a specific severity band | confirmed | an audit of ng222 practice applies 'less severe' as phq-9 under 16. this is a secondary source, and its abstract does not quote the guideline's definition directly. [4] |
both directions
for the speaker: ng222 moved antidepressants out of the routine first-line slot for less severe depression and kept them only as a preference-driven option. individual cbt sits in the top four of nice's ranked first-line list, ahead of medication. a peer-reviewed comparison of the nice and australian/new zealand guidelines describes cbt and medication as nice's leading treatments across severity levels. the trial evidence does not show medication outperforming psychotherapy in the short term, and it hints that psychotherapy holds up better at 6-12 months. so the direction the speaker describes, with nice favouring talking therapy over drugs for milder depression, matches the record.
against: "works better" claims more than the ranking can carry. nice orders its options partly on cost and implementation, which is why group formats and guided self-help come before individual cbt. nice also says any option can be used first line if the person prefers it, including antidepressants. the largest pooled comparison we read found psychotherapy and medication equivalent at the end of treatment (rr 0.99). that analysis was dominated by moderate to severe depression, so it cannot by itself settle what happens in milder cases in either direction. for more severe depression, the secondary sources describe nice placing medication and individual cbt in the leading positions, with combined treatment favoured.
what this cannot say
nice.org.uk and the ncbi bookshelf copy of ng222 refused automated access, so the guideline's exact wording and the committee's written rationale reach us through peer-reviewed papers that quote it, not from the document itself. we also read nice's one-page visual summary through an nhs board's copy. it shows ssri antidepressants eighth of 11 in order of recommended use and states 'do not routinely offer antidepressants as a first-line treatment, unless that is the person's preference'. that host is not on our citation list, so it is not listed as a source. the trial evidence we cite pools mostly moderate to severe depression, and it measures symptom scores at the end of treatment, not everything a person might weigh. we did not verify what earlier statement the speaker's 'same conclusion' referred to.
sources, each one fetched and read
- Should antidepressants be prescribed simply if it is the patient's preference? British Journal of General Practice, 2026, doi:10.3399/bjgp26X743853 What we read there: ng222 "does not recommend antidepressants as a routine or first-line treatment for less severe depression"; first-line options include guided self-help, group behavioural activation, group cbt and structured physical activity; antidepressants "may be offered only if this is the person's preference". Fetched 2026-10-13 (HTTP 200). https://pmc.ncbi.nlm.nih.gov/articles/PMC13044197/
- Positioning of psychodynamic psychotherapy in the treatment of depression: a comparison of the RANZCP 2020 and NICE 2022 guidelines. Australasian Psychiatry, 2023, doi:10.1177/10398562231159329 What we read there: nice ng222 ranks 11 first-line treatments for less severe depression; group therapies rank highest for cost reasons; individual cbt and behavioural activation are in the top four; short-term psychodynamic psychotherapy is ranked last. Fetched 2026-10-13 (HTTP 200). https://pmc.ncbi.nlm.nih.gov/articles/PMC10251463/
- A network meta-analysis of the effects of psychotherapies, pharmacotherapies and their combination in the treatment of adult depression. World Psychiatry, 2020;19(1):92-107, doi:10.1002/wps.20701 What we read there: 101 studies, 11,910 patients; depression in most studies was moderate to severe; no significant difference between psychotherapy alone and pharmacotherapy alone (rr 0.99; 95% ci 0.92-1.08); indications psychotherapy more effective at longer follow-up; combination seems best for moderate depression. Fetched 2026-10-13 (HTTP 200). https://pmc.ncbi.nlm.nih.gov/articles/PMC6953550/
- A retrospective clinical audit on depression management in line with NICE NG222 guidelines at a primary care setting in rural England. European Psychiatry, 2026;69(Suppl 1):S141-S142, doi:10.1192/j.eurpsy.2026.10588 What we read there: audits '11 patients with less-severe depression (PHQ-9<16)' against the standard of offering non-pharmacological treatment first and not offering antidepressants first-line without documented patient preference. Fetched 2026-10-13 (HTTP 200). https://pmc.ncbi.nlm.nih.gov/articles/PMC13442253/
speakers are described by role, not named. one sentence is quoted under fair use, with attribution and a link to the original at the timestamp; we do not re-host audio or video. nothing on this page is a reason to start, stop or change a medication. if you have the file behind anything marked unverifiable, the research board is where people can answer. adam